These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 17428147

  • 1. Stereoselectivity in drug metabolism.
    Lu H.
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
    [Abstract] [Full Text] [Related]

  • 2. Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics.
    Brocks DR.
    Biopharm Drug Dispos; 2006 Nov; 27(8):387-406. PubMed ID: 16944450
    [Abstract] [Full Text] [Related]

  • 3. Pharmacologically active compounds in the environment and their chirality.
    Kasprzyk-Hordern B.
    Chem Soc Rev; 2010 Nov; 39(11):4466-503. PubMed ID: 20852776
    [Abstract] [Full Text] [Related]

  • 4. Effect of chirality on pharmacokinetics and pharmacodynamics.
    Crom WR.
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S9-14. PubMed ID: 1530005
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetics of chiral drugs].
    Bernareggi A.
    Boll Chim Farm; 1995 Feb; 134(2):63-8. PubMed ID: 7598834
    [Abstract] [Full Text] [Related]

  • 6. Biological significance of the enantiomeric purity of drugs.
    Waldeck B.
    Chirality; 1993 Feb; 5(5):350-5. PubMed ID: 8398592
    [Abstract] [Full Text] [Related]

  • 7. Input rate-dependent stereoselective pharmacokinetics: effect of pulsatile oral input.
    Mehvar R.
    Chirality; 1994 Feb; 6(3):185-95. PubMed ID: 8024949
    [Abstract] [Full Text] [Related]

  • 8. Microseparation techniques for the study of the enantioselectivity of drug-plasma protein binding.
    Escuder-Gilabert L, Martínez-Gómez MA, Villanueva-Camañas RM, Sagrado S, Medina-Hernández MJ.
    Biomed Chromatogr; 2009 Mar; 23(3):225-38. PubMed ID: 19016227
    [Abstract] [Full Text] [Related]

  • 9. [Chirality and drugs].
    Testa B, Reist M, Carrupt PA.
    Ann Pharm Fr; 2000 Jul; 58(4):239-46. PubMed ID: 10915971
    [Abstract] [Full Text] [Related]

  • 10. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
    Aboul-Enein HY, El-Awady MI, Heard CM, Nicholls PJ.
    Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chiral toxicology: it's the same thing...only different.
    Smith SW.
    Toxicol Sci; 2009 Jul; 110(1):4-30. PubMed ID: 19414517
    [Abstract] [Full Text] [Related]

  • 15. Chirality and pharmacokinetics: an area of neglected dimensionality?
    Hutt AJ.
    Drug Metabol Drug Interact; 2007 Jul; 22(2-3):79-112. PubMed ID: 17708062
    [Abstract] [Full Text] [Related]

  • 16. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q, Yu LS, Zeng S.
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Stereoselective determination of drugs and metabolites in body fluids, tissues and microsomal preparations by capillary electrophoresis (2000-2010).
    Caslavska J, Thormann W.
    J Chromatogr A; 2011 Jan 28; 1218(4):588-601. PubMed ID: 20869061
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.